1. Home
  2. RMD

RMD

ResMed Inc.

Logo ResMed Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Founded: 1989 Country:
United States
United States
Employees: 10140 City: SAN DIEGO
Market Cap: 27.3B IPO Year: 1995
Target Price: $208.70 AVG Volume (30 days): 1.0M
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield: 1.03% Dividend Payout Frequency: Quarterly
EPS: 6.05 EPS Growth: 9.80
52 Week Low/High: $132.24 - $243.52 Next Earning Date: 04-25-2024
Revenue: $4,504,077,000 Revenue Growth: 19.69%
Revenue Growth (this year): 10.82% Revenue Growth (next year): 6.22%

Share on Social Networks: